Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 246-255, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcovina, S. M.
Right arrow Articles by Gaur, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcovina, S. M.
Right arrow Articles by Gaur, V. P.

Clinical Chemistry, Vol 41, 246-255, Copyright © 1995 by American Association for Clinical Chemistry

Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)

SM Marcovina, JJ Albers, B Gabel, ML Koschinsky and VP Gaur
Department of Medicine, Northwest Lipid Research Laboratories, University of Washington, Seattle 98103.

Lipoprotein(a) [Lp(a)] has been measured in numerous clinical and epidemiological studies by a variety of immunochemical methods. However, little, if any, consideration has been given to the confounding effect of the size heterogeneity of apolipoprotein(a) [apo(a)] on the measurement of Lp(a). We developed three direct-binding enzyme-linked immunosorbent assays (ELISAs) with detecting antibodies of different specificities to evaluate the effect of apo(a) size on Lp(a) measurement. The three assays used the same monoclonal antibody to capture the apo(a)-containing particles and were calibrated (in nanomoles per liter) with a serum containing apo(a) with 21 kringle 4 domains. Using all three ELISAs, we measured Lp(a) in a group of 723 subjects selected to have a single apo(a) band, as determined by a high- resolution phenotyping system. Essentially identical results were obtained by the two methods that measured Lp(a) by use of either a polyclonal antibody against apo B or a monoclonal antibody against apo(a) that does not recognize the kringle 4 type 2 repeats. In contrast, the ELISA using a monoclonal antibody specific for apo(a) kringle 4 type 2 repeats overestimated Lp(a) concentration in samples containing apo(a) with more than 21 kringle 4 domains and underestimated Lp(a) samples containing apo(a) with fewer than 21 kringle 4 domains. Thus, these differences in Lp(a) values varied as a function of apo(a) size. We conclude that antibody specificity and apo(a) size heterogeneity can significantly affect Lp(a) measurements.


The following articles in journals at HighWire Press have cited this article:


Home page
 JAMAHome page
P. R. Kamstrup and B. G. Nordestgaard
Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction--Reply
JAMA, October 21, 2009; 302(15): 1645 - 1646.
[Full Text] [PDF]

Home page
 JAMAHome page
The Emerging Risk Factors Collaboration
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA, July 22, 2009; 302(4): 412 - 423.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y.-T. Wang, A. von Zychlinski, and S. P. A. McCormick
Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a)
J. Lipid Res., May 1, 2009; 50(5): 846 - 853.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Ober, A. S. Nord, E. E. Thompson, L. Pan, Z. Tan, D. Cusanovich, Y. Sun, R. Nicolae, C. Edelstein, D. H. Schneider, et al.
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q
J. Lipid Res., May 1, 2009; 50(5): 798 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. O. Lowe, J. Danesh, and V. Gudnason
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data
Arch Intern Med, March 24, 2008; 168(6): 598 - 608.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al.
Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 735 - 742.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B. G. Nordestgaard
Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study
Circulation, January 15, 2008; 117(2): 176 - 184.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. T. Jones, A. M. van Rij, J. Cole, M. J.A. Williams, E. H. Bateman, S. M. Marcovina, M. Deng, and S. P.A. McCormick
Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease
Clin. Chem., April 1, 2007; 53(4): 679 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. C. Carr, R. H. Knopp, J. D. Brunzell, B. S. Wheeler, X. Zhu, M. Lakshmanan, A. S. Rosen, and P. W. Anderson
Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy
Diabetes Care, July 1, 2005; 28(7): 1555 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. C. Longenecker, M. J. Klag, S. M. Marcovina, Y.-M. Liu, B. G. Jaar, N. R. Powe, N. E. Fink, A. S. Levey, and J. Coresh
High Lipoprotein(a) Levels and Small Apolipoprotein(a) Size Prospectively Predict Cardiovascular Events in Dialysis Patients
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1794 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Schneider, J. L. Witztum, S. G. Young, E. H. Ludwig, E. R. Miller, S. Tsimikas, L. K. Curtiss, S. M. Marcovina, J. M. Taylor, R. M. Lawn, et al.
High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins
J. Lipid Res., April 1, 2005; 46(4): 769 - 778.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. Guerra, Z. Yu, S. Marcovina, R. Peshock, J. C. Cohen, and H. H. Hobbs
Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study
Circulation, March 29, 2005; 111(12): 1471 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. N.M. Demacker, E. Bolat, H. I. Toenhake-Dijkstra, and L. J.H. van Tits
Factors Influencing Isoprotein Dependency of Polyclonal Apolipoprotein(a) Assays
Clin. Chem., November 1, 2004; 50(11): 2161 - 2163.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Rifai, J. Ma, F. M. Sacks, P. M. Ridker, W. J. L. Hernandez, M. J. Stampfer, and S. M. Marcovina
Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study
Clin. Chem., August 1, 2004; 50(8): 1364 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Y. Y. Liu, R. Broadhurst, S. M. Marcovina, and S. P. A. McCormick
Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation
J. Lipid Res., January 1, 2004; 45(1): 63 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
Clin. Chem., November 1, 2003; 49(11): 1785 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Sharp, M. A. Perugini, S. M. Marcovina, and S. P.A. McCormick
A Synthetic Peptide That Inhibits Lipoprotein(a) Assembly
Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 502 - 507.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. C. Longenecker, M. J. Klag, S. M. Marcovina, N. R. Powe, N. E. Fink, F. Giaculli, and J. Coresh
Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal Disease: The CHOICE Study
Circulation, November 26, 2002; 106(22): 2812 - 2818.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. Faggin, A. Zambon, M. Puato, S. S. Deeb, S. Bertocco, S. Sartore, G. Crepaldi, A. C. Pessina, and P. Pauletto
Association between the -514 c->t polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1059 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. K. Plenge, T. L. Hernandez, K. M. Weil, P. Poirier, G. K. Grunwald, S. M. Marcovina, and R. H. Eckel
Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction
Circulation, September 17, 2002; 106(12): 1447 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, E. De Amici, D. Geroldi, and P. Fratino
Assessment of Asymptomatic Coronary Artery Disease in Apparently Uncomplicated Type 2 Diabetic Patients: A role for lipoprotein(a) and apolipoprotein(a) polymorphism
Diabetes Care, August 1, 2002; 25(8): 1418 - 1424.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Ichikawa, H. Unoki, H. Sun, H. Shimoyamada, S. Marcovina, H. Shikama, T. Watanabe, and J. Fan
Lipoprotein(a) Promotes Smooth Muscle Cell Proliferation and Dedifferentiation in Atherosclerotic Lesions of Human Apo(a) Transgenic Rabbits
Am. J. Pathol., January 1, 2002; 160(1): 227 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser
Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints
Am. J. Pathol., October 1, 2001; 159(4): 1445 - 1453.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
S. M. Marcovina, J. J. Albers, A. M. Scanu, H. Kennedy, F. Giaculli, K. Berg, R. Couderc, F. Dati, N. Rifai, I. Sakurabayashi, et al.
Use of a Reference Material Proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to Evaluate Analytical Methods for the Determination of Plasma Lipoprotein(a)
Clin. Chem., December 1, 2000; 46(12): 1956 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Yamada, R. Morishita, S. Nakamura, T. Ogihara, Y. Kusumi, I. Sakurai, N. Kubo, and I. Sakurabayashi
Development of Antibody Against Epitope of Lipoprotein(a) Modified by Oxidation : Evaluation of New Enzyme-Linked Immunosorbent Assay for Oxidized Lipoprotein(a)
Circulation, October 3, 2000; 102(14): 1639 - 1644.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. Xia, L. F. May, and M. L. Koschinsky
Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity
J. Lipid Res., October 1, 2000; 41(10): 1578 - 1584.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
J. Fan, M. Challah, H. Shimoyamada, M. Shiomi, S. Marcovina, and T. Watanabe
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
J. Lipid Res., June 1, 2000; 41(6): 1004 - 1012.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
J. R. Guyton, M. A. Blazing, J. Hagar, M. L. Kashyap, R. H. Knopp, J. M. McKenney, D. T. Nash, S. D. Nash, and for the Niaspan-Gemfibrozil Study Group
Extended-Release Niacin vs Gemfibrozil for the Treatment of Low Levels of High-Density Lipoprotein Cholesterol
Arch Intern Med, April 24, 2000; 160(8): 1177 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. G. Shlipak, J. A. Simon, E. Vittinghoff, F. Lin, E. Barrett-Connor, R. H. Knopp, R. I. Levy, and S. B. Hulley
Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause
JAMA, April 12, 2000; 283(14): 1845 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
V. Mooser, N. Helbecque, J. Miklossy, S. M. Marcovina, P. Nicod, and P. Amouyel
Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease
Ann Intern Med, April 4, 2000; 132(7): 533 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero
Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1137 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. KRONENBERG, E. KUEN, E. RITZ, R. JUNKER, P. KÖNIG, G. KRAATZ, K. LHOTTA, J. F. E. MANN, G. A. MÜLLER, U. NEYER, et al.
Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 105 - 115.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
G. M. Kostner, A. Ibovnik, H. Holzer, and H. Grillhofer
Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard
J. Lipid Res., December 1, 1999; 40(12): 2255 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. Tao, F. Acquati, S. M. Marcovina, and H. H. Hobbs
Human Growth Hormone Increases Apo(a) Expression in Transgenic Mice
Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2439 - 2447.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. M. Marcovina and M. L. Koschinsky
Lipoprotein(a) Concentration and Apolipoprotein(a) Size : A Synergistic Role in Advanced Atherosclerosis?
Circulation, September 14, 1999; 100(11): 1151 - 1153.
[Full Text] [PDF]

Home page
 CirculationHome page
F. Kronenberg, M. F. Kronenberg, S. Kiechl, E. Trenkwalder, P. Santer, F. Oberhollenzer, G. Egger, G. Utermann, and J. Willeit
Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis : Prospective Results From the Bruneck Study
Circulation, September 14, 1999; 100(11): 1154 - 1160.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. Periard, A. Telenti, P. Sudre, J.-J. Cheseaux, P. Halfon, M. J. Reymond, S. M. Marcovina, M. P. Glauser, P. Nicod, R. Darioli, et al.
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Circulation, August 17, 1999; 100(7): 700 - 705.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. J. Seman, C. DeLuca, J. L. Jenner, L. A. Cupples, J. R. McNamara, P. W.F. Wilson, W. P. Castelli, J. M. Ordovas, and E. J. Schaefer
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Clin. Chem., July 1, 1999; 45(7): 1039 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density
Circulation, April 20, 1999; 99(15): 1959 - 1964.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. Fontana, V. Mooser, P. Bovet, C. Shamlaye, B. Burnand, V. Lenain, S. M. Marcovina, W. Riesen, and R. Darioli
Dose-Dependent Inverse Relationship Between Alcohol Consumption and Serum Lp(a) Levels in Black African Males
Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1075 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Wehinger, A. Kastrati, S. Elezi, H. Baum, S. Braun, F.-J. Neumann, and A. Schomig
Lipoprotein(a) and coronary thrombosis and restenosis after stent placement
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Dangas, R. Mehran, P. C. Harpel, S. K. Sharma, S. M. Marcovina, G. Dube, J. A. Ambrose, and J. T. Fallon
Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2035 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. E. Cummings, N. Kumar, C. W. Bardin, K. Sundaram, and W. J. Bremner
Prostate-Sparing Effects in Primates of the Potent Androgen 7{alpha}-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4212 - 4219.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
N. Emanuele, N. Azad, C. Abraira, W. Henderson, J. Colwell, S. Levin, F. Nuttall, J. Comstock, C. Sawin, C. Silbert, et al.
Effect of Intensive Glycemic Control on Fibrinogen, Lipids, and Lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus
Arch Intern Med, December 1, 1998; 158(22): 2485 - 2490.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Y. Craig, L. M. Neveux, G. E. Palomaki, M. M. Cleveland, and J. E. Haddow
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Clin. Chem., November 1, 1998; 44(11): 2301 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Su, H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks
Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3267 - 3276.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Rand, W. Sangrar, M. A. Hancock, D. M. Taylor, S. M. Marcovina, M. A. Packham, and M. L. Koschinsky
Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1393 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Rainwater and S. M. Haffner
Insulin and 2-Hour Glucose Levels Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype
Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1335 - 1341.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. R. Tate, N. Rifai, K. Berg, R. Couderc, F. Dati, G. M. Kostner, I. Sakurabayashi, and A. Steinmetz
International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators
Clin. Chem., August 1, 1998; 44(8): 1629 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Jialal
Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein
Clin. Chem., August 1, 1998; 44(8): 1827 - 1832.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. Q. Purnell, J. E. Hokanson, S. M. Marcovina, M. W. Steffes, P. A. Cleary, and J. D. Brunzell
Effect of Excessive Weight Gain With Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood Pressure: Results From the DCCT
JAMA, July 8, 1998; 280(2): 140 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
E. Kim and S. G. Young
Genetically modified mice for the study of apolipoprotein B
J. Lipid Res., April 1, 1998; 39(4): 703 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2783 - 2792.
[Abstract] [Full Text]

Home page
 CirculationHome page
M. Poon, X. Zhang, K. G. Dunsky, M. B. Taubman, and P. C. Harpel
Apolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial Cells
Circulation, October 21, 1997; 96(8): 2514 - 2519.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young
Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a)
J. Biol. Chem., September 19, 1997; 272(38): 23616 - 23622.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. H. Wild, S. P. Fortmann, and S. M. Marcovina
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 239 - 245.
[Abstract] [Full Text]

Home page
 CirculationHome page
S. P. Fortmann and S. M. Marcovina
Lipoprotein(a), a Clinically Elusive Lipoprotein Particle
Circulation, January 21, 1997; 95(2): 295 - 296.
[Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
B. R. Gabel, L. F. May, S. M. Marcovina, and M. L. Koschinsky
Lipoprotein(a) Assembly: Quantitative Assessment of the Role of Apo(a) Kringle IV Types 2-10 in Particle Formation
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1559 - 1567.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Kronenberg, E. Trenkwalder, H. Dieplinger, and G. Utermann
Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time: Why Epidemiological Studies Might Fail
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1568 - 1572.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Hoover-Plow, N. Boonmark, P. Skocir, R. Lawn, and E. F. Plow
A Quantitative Immunoassay for the Lysine-Binding Function of Lipoprotein(a) : Application to Recombinant Apo(a) and Lipoprotein(a) in Plasma
Arterioscler Thromb Vasc Biol, May 1, 1996; 16(5): 656 - 664.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. D. O'Brien, D. D. Reichenbach, S. M. Marcovina, J. Kuusisto, C. E. Alpers, and C. M. Otto
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of `Degenerative' Valvular Aortic Stenosis
Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 523 - 532.
[Abstract] [Full Text]

Home page
 JAMAHome page
V. M. G. Maher, B. G. Brown, S. M. Marcovina, L. A. Hillger, X.-Q. Zhao, and J. J. Albers
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
JAMA, December 13, 1995; 274(22): 1771 - 1774.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Averna, S. M. Marcovina, D. Noto, T. G. Cole, E. S. Krul, and G. Schonfeld
Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a)
Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2165 - 2175.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F.P. Mancini, D.L. Newland, V. Mooser, J. Murata, S. Marcovina, S.G. Young, R.E. Hammer, D.A. Sanan, and H.H. Hobbs
Relative Contributions of Apolipoprotein(a) and Apolipoprotein-B to the Development of Fatty Lesions in the Proximal Aorta of Mice
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1911 - 1916.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
E. J. Cheesman, R. J. Sharp, C. H. Zlot, C. Y.-Y. Liu, S. Taylor, S. M. Marcovina, S. G. Young, and S. P. A. McCormick
An Analysis of the Interaction between Mouse Apolipoprotein B100 and Apolipoprotein(a)
J. Biol. Chem., September 1, 2000; 275(36): 28195 - 28200.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Becker, R. S. McLeod, S. M. Marcovina, Z. Yao, and M. L. Koschinsky
Identification of a Critical Lysine Residue in Apolipoprotein B-100 That Mediates Noncovalent Interaction with Apolipoprotein(a)
J. Biol. Chem., September 21, 2001; 276(39): 36155 - 36162.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.